INF904
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for INF904, covering 2026-02-03 to 2026-02-03. Get the full timeline:
Most recent: Clinical Trial Update: Evaluate Safety and Pharmacokinetics of INF904 in Subjects With Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis Suppurativa [Phase 2]